INTERNATIONAL PATENT: ANNOVIS BIO, INC. FILES APPLICATION FOR "TREATMENT OF DISEASES VIA ADMINISTRATION OF BUNTANETAP AND AN ANTIDIABETIC AGENT"

GENEVA, Aug. 5 -- ANNOVIS BIO, INC. (101 Lindenwood Drive, Suite #225Malvern, PA 19355) filed a patent application (PCT/US2024/045748) for "TREATMENT OF DISEASES VIA ADMINISTRATION OF BUNTANETAP AND AN ANTIDIABETIC AGENT" on Sep 08, 2024. With publication no. WO/2025/159798, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MACCECCHINI, Maria (1223 Fox Glove LaneWest Chester, PA 19380-5854)

Abstract: The invention relates to methods and pharmaceutical compositions effective for treating, inhibiting, preventing, slowing, ...